XML 35 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 8 - Stock Compensation Plans
12 Months Ended
Feb. 29, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE 8 - STOCK COMPENSATION PLANS

In FY 2008, shareholders approved the 2007 Equity Incentive Plan (the “2007 Plan”).  The 2007 Plan allows awards of stock options; stock appreciation rights; stock awards, restricted stock and stock units; performance shares and performance units; other stock or cash based awards.  As of February 29, 2012, 219,240 restricted stock units, 12,936 stock options and 16,000 unrestricted shares have been awarded under the 2007 Plan and 201,416 shares of common stock is available for award under the plan consisting of 300,000 shares originally authorized, 85,340 previously reserved for issuance under earlier plans and 64,252 shares forfeited under the 2007 Plan and suspended plans, less shares awarded under the Plan.

Under the 1995 Stock Option Plan (the “1995 Plan”), the 2004 Stock Option Plan (the “2004 Plan”), the Nonqualified Stock Option Plan for Nonemployee Directors (the “Director’s Plan”) and the 2000 Nonqualified Stock Option Plan for Nonemployee Directors (the “2000 Director’s Plan”), options to purchase up to 970,200, 441,000, 279,720 and 291,060 shares, respectively, of the Company’s common stock were previously authorized to be granted at prices not less than market value at the date of grant. Options granted may not have a term exceeding ten years under the 1995 plan, the 2004 plan and the Director’s Plan. Options granted may not have a term exceeding five years under the 2000 Director’s Plan. Options representing the right to purchase 18,191, 266,259, 0, 9,702, and 12,936 shares of the Company’s common stock were outstanding under the 1995 Plan, the 2004 Plan, the Director’s Plan, the 2000 Director’s Plan, and the 2007 Plan, respectively, at February 29, 2012. On February 21, 2006, the Company accelerated the vesting of all outstanding stock options in order to prevent past option grants from having an impact on future results. The options outstanding under these plans will expire, if not exercised through February 2016.

Information with respect to stock option awards outstanding under the plans at February 29, 2012, and changes for the three years then ended was as follows:

   
Twelve Months Ended
 
   
February 28 or 29:
 
 
 
2012
   
2011
   
2010
 
Outstanding stock options at beginning of year:
    341,890       367,762       371,437  
Granted
    12,936       -       -  
Exercised
    (45,113 )     (6,468 )     -  
Cancelled/forfeited
    (2,625 )     (19,404 )     (3,675 )
Outstanding stock options as of February 28 or 29:
    307,088       341,890       367,762  
                         
Weighted average exercise price
  $ 10.84     $ 9.83     $ 9.92  
Weighted average remaining contractual term (in years)
    2.76       3.36       4.10  

Information with respect to restricted stock unit awards outstanding under the plans at February 29, 2012, and changes for the three years then ended was as follows:

   
Twelve Months Ended
 
   
February 28 or 29:
 
 
 
2012
   
2011
   
2010
 
Outstanding non-vested restricted stock units at beginning of year:
    141,260       129,280       165,400  
Granted
    4,540       44,300       -  
Vested
    (43,300 )     (32,320 )     (33,080 )
Cancelled/forfeited
    (520 )     -       (3,040 )
Outstanding non-vested restricted stock units as of February 28 or 29:
    101,980       141,260       129,280  
                         
Weighted average grant date fair value
  $ 9.19     $ 9.17     $ 9.04  
Weighted average remaining vesting period (in years)
    2.00       2.96       3.41  

Additional information about stock options outstanding at February 29, 2012 is summarized as follows:

   
Options Outstanding
Range of exercise prices
 
Number exercisable
   
Weighted average remaining contractual life
   
Weighted average exercise price
$3.298
    18,191       1.23     $ 3.30  
$7.408 to $7.415
    172,284       2.30     $ 7.41  
$13.162 to $20.571
    116,613       3.66     $ 17.09